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Abstract 
A recombinant construct encoding for the expression of an insecticidal fusion protein 
comprised ofcontaining the spider-venom peptide -hexatoxin-Hv1a (Hv1a), from 
the venom of the funnel web spider Hadronyche versuta, linked to the snowdrop 
lectin (Galanthus nivalis agglutinin;  (GNA) has been shown to be an effective oral 
insecticide against lepidopteran larve. The construct for producing the Hv1a/GNA 
fusion protein in P. pastoris has been modified to improve levels of intact 
recombinant protein recoverable from fermented culture supernatants. by sSite 
directed mutagenesis to remove a potential Kex2 cleavage site at the C-terminus of 
the Hv1a peptide. The modifed construct resulted in markedly increased levels of 
intact fusion protein expressed in wild type, but not protease deficient, P. pastoris 
strains, improving levels of intact recombinant protein recoverable from culture 
supernatants. indicative of increased resistance to yeast proteases. Injection assays of 
purified fusion protein in lepidopteran larvae demonstrated that sequence 
modification did not affect the insecticidal activity of the recombinant toxin. The 
incorporation of a C-terminal (histidine)6 tag in the modified construct enabled a 
single step purification of the fusion protein from fermenter supernatants derived from 
bench-top fermentation.  A straightforward method for producing multicopy 
expression plasmids for production of recombinant proteins in P. pastoris is 
described, which does not rely on multiple integrations to give clones of P. pastoris 
containing high copy numbers of the introduced gene. The method has been used to 
increase production of the secreted recombinant fusion protein in a pilot scale 
laboratory fermentation system by almost 10-fold on a per litre of culture basis, 
providing a means to allow evaluation as a commercial biopesticide. 
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Introduction 
The methylotrophic yeast Pichia pastoris has established itself as the eukaryotic 
expression system of choice for large-scale production of recombinant proteins, which 
do not fold well in prokaryotes. The system has a major advantage over 
Saccharomyces spp. in that it contains an efficient secretion system, which can direct 
large amounts of recombinant protein into the culture medium, making purification of 
the desired product straightforward. Although its limited capacity for protein 
glycosylation limits its use for production of mammalian glycoproteins, it is an ideal 
host for producing small proteins with a high content of disulphide bridges, which 
require the conditions of a eukaryotic endoplasmic reticulum compartment to fold to 
biologically active forms ([1] Daly & Hearn, 2005). Typical of this use is the 
production of snowdrop lectin (Galanthus nivalis agglutinin, GNA), which is secreted 
as a fully active folded protein (Raemaekers et al 1999 [2] Baumgartner et al., 
2003[3]), whereas expression in E. coli results in an insoluble inclusion body, from 
which GNA can only be recovered by a process of denaturation and renaturation ([4] 
Sulan et. al., 2005). 
 
Snowdrop lectin (Galanthus nivalis agglutinin; GNA) has been used as a "carrier" 
domain in the production of recombinant insecticidal fusion proteins, where it confers 
oral toxicity on peptide toxins from scorpions and spiders ([5-9] Fitches et al., 2004; 
2010; 2012; Down et al., 2006; Trung et al., 2006). Oral toxicity is achieved via 
delivery of attached toxins, by GNA, to the central nervous system of target pests. 
These toxins themselves contain multiple disulphide bonds, and expression in E. coli 
gives products that require careful refolding to give any activity; in contrast, fusion 
proteins where the toxin has full biological activity can be produced directly in P. 
pastoris. As a result, production of fusion proteins on a scale to allow them to be used 
as pesticides has become possible, but is limited by the economic cost of the 
fermentation system. To decrease costs, and generate an economically viable product, 
yields of the recombinant fusion protein must be increased as far as possible. The 
recombinant insecticidal fusion protein Hv1a/GNA, containing -hexatoxin-Hv1a 
(Hv1a), from the venom of the funnel web spider Hadronyche versuta, linked to GNA 
has previously been shown to be orally active against lepidopteran larvae, and has 
been selected as a "best candidate" in terms of potential for development as a 
biopesticide ([7] Fitches et. al., 2012). 
 
To maximise expression of recombinant proteins in P. pastoris, investigators have 
often used constructs driven by the alcohol oxidase (AOX1) promoter, where 
expression can be induced by addition of methanol to a growing culture. Experiments 
with fusion protein production have shown that better expression was achieved with 
the constitutively expressed GAP promoter, which is also advantageous for industrial 
production in not requiring a methanol feed.  
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Previous studies have shown that insecticidal fusion proteins are prone to degradation 
by yeast extracellular proteases during production by bench-top fermentation (Fitches 
[5,7,9] et al., 2004; 2012; Trung et al., 2006). Proteolysis occurs predominantly at or 
near the linker region between the insecticidal peptide and the carrier protein resulting 
in a reduction in yields of intact protein. Proteolysis is particularly evident when 
fusion proteins are expressed using wild type X33 P. pastoris strain. The use of the P. 
pastoris strain SMD1168H, which is deficient in the extracellular vacuole peptidase A 
(pep4), responsible for activating carboxypeptidase Y and protease B1, has been 
found to reduce proteolysis allowing for an increase in yields of intact fusion protein 
to be achieved. However, X33 is the strain of choice for large-scale production, as 
recombinant protein production levels in the protease deficient strain tend to be lower 
than the more robust wild type strain ([10] Gilleson et al. 1998). In this study the 
removal of a potential Kex2 cleavage site present in the Hv1a toxin sequence has 
been shown to significantly reduce proteolysis in the wild type strain. A comparison 
of levels of intact fusion protein obtained by bench-top fermentation using X33 and 
protease deficient strains have shown that yields from X33 cells can be almost double 
that obtained using protease deficient strain.  
 
Previous work has also shown that engineering multiple copies of an expression 
construct into the Pichia genome can result in increases in expression levels ([11,12] 
Vassileva et. al., 2001, Mansur et. al., 2005); with recombinant protein production 
increasing with increasing copy number to an optimum, after which further increasing 
the copy number results in decreased expression ([13] Zhu et. al., 2009). The 
experiments described in this paper show that the multicopy strategy for maximising 
recombinant protein expression is also applicable to constructs based on a constitutive 
promoter, and identify an optimum transgene copy number for engineered P. pastoris 
strains producing the insecticidal Hv1a/GNA fusion protein. 
 
Materials and Methods 
Materials and recombinant techniques 
General molecular biology protocols were as described in Sambrook & Russell ([14] 
2001) except where otherwise noted. Subcloning was carried out using the TOPO 
cloning kit (pCR2.1 TOPO vector; Invitrogen). Pichia pastoris wild type X33 and 
SMD1168H (protease A deficient) strains, the expression vector pGAPZαB, and 
Easycomp Pichia transformation kit were from Invitrogen. Gel extraction was carried 
out using Qiagen gel extraction kits. Oligonucleotide primers were synthesised by 
Sigma-Genosys Ltd. and restriction endonucleases were purchased from Fermentas. 
Plasmid DNA was prepared using Promega Wizard miniprepkits. T4 polynucleotide 
kinase and T4 DNA ligase were supplied by Promega. Phusion polymerase was from 
New England BioLabs. GNA was produced as a recombinant protein in yeast using a 
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clone generated as previously described ([13] Raemaekers et al., 1999). Polyclonal 
anti-GNA antibodies (raised in rabbits) were prepared by Genosys Biotechnologies, 
Cambridge, UK. Chemiluminescence detection reagents (coumaric acid and luminol) 
were supplied by Sigma.  
 
All DNA sequencing was carried out using dideoxynucleotide chain termination 
protocols on Applied Biosystems automated DNA sequencers by the DNA 
Sequencing Service, School of Biological and Biomedical Sciences, University of 
Durham, UK. Sequences were checked and assembled using Sequencher software 
running on Mac OS computers. 
 
Construct preparation 
The generation of a construct encoding for the mature omega peptide (Hv1a) linked to 
the N-terminus of GNA has been previously reported ([7] Fitches et al., 2012). A 
potential Kex2 cleavage site present in the Hv1a peptide sequence was removed and a 
construct was created whereby residue number 34 in the toxin (lysine; K) was 
replaced by a glutamine (Q) by site directed mutagenesis (Fig. 1a). The Hv1a 
sequence was modified by PCR using primers encoding a 5’ Pst I site and a 3’ primer 
encoding a modified C-terminus (as above) and Not I site. The PCR product was 
restricted and ligated into similarly digested Hv1a/GNApGAPZB to create 
MODHv1a/GNApGAPZB. A histidine tag was subsequently incorporated at the C-
terminus of the fusion protein gene cassette by PCR amplification of 
MODHv1a/GNA using a 3’ primer coding for six histidine residues, a stop codon and 
an Xba I restriction site. The PCR product (~500bp) was digested with Pst I/Xba I and 
ligated into pGAPZB vector digested with same enzymes, to create 
MODHv1a/GNA/His in pGAPZB. All constructs were verified by sequencing prior 
to yeast transformation. 
 
To enable the insertion of multiple fusion protein cassettes into the yeast genome, the 
pGAPZB vector was modified to contain a Hind III site in the GAP promoter region 
by site directed mutagenesis (as Bln I could not be used for linearisation of vector 
prior to yeast transformation). Primers were designed to introduce Hind III site 35 bp 
from the Bln I site in the GAP promoter region, Forward (5’ 
CATTACGTTGCGGGTAAAACGG) and reverse (5’ 
CTGGGAAGAAGCTTGCTGCAAG), where AATGCT sequence from original GAP 
region was changed to AAGCTT. PCR was performed using MODHv1a/GNA/His 
pGAPZB vector template DNA and Phusion polymerase. The PCR product (~3.6kb) 
was phosphorylated using T4 polynucleotide kinase kit as per manufacturer’s 
instructions, gel purified, and the DNA was then re-ligated using T4 DNA ligase. Re-
ligated vector was transformed into E.coli (TOP10) cells and plasmid DNA was 
sequenced (using primers; Forward- 5’ GTAGAAATGTCTTGGTGTCC and 
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Reverse- 5’ AGTCTTTGGGTCAGGAGAAA) to verify the presence of a Hind III 
site in GAP region. 
 
Transformation of single and multi copy expression cassettes  
Single copy, 3 copy, 5 copy, 7 copy and 11 copy expression construct plasmids were 
assembled using standard molecular biology methods, as described below. 
Each expression cassette consisted of pGAP region, alpha factor secretary signal, 
MODHv1a/GNA, six residue His tag followed by an AOX1 transcription terminator 
(Fig. 2a). This cassette was restricted from the backbone vector using Bam HI and Bgl 
II. The vector into which this cassette was to be introduced, already containing an 
expression cassette, was linearised with Bam HI. After ligation of the expression 
cassette, the correct resulting circular plasmid contains the unchanged Bgl II site, an 
intact reformed BamH I site, and The cassette was then inserted utilizing the 
uniqueness of Bam HI sitea hybrid BamH I / Bgl II site (Bam HI and Bgl II produce 
compatible overhangs) between the original and introduced expression cassettes, and 
the site is modified after ligation such that it is recognizedwhich cannot be digested 
by neither enzymes). It can then be linearised with BamH I to introduce further 
Additional expression cassettes were introduced using the same methods. Each time 
the plasmids were confirmed for the insertion of morefurther cassettes were inserted, 
the recombinant plasmid was checked either by releasing the complete set of cassettes 
(using Bam HI and Bgl II) or linearising the whole plasmid (using Bam HI). An 
overview of the preparation of multiple cassettes is shown in Fig. 2b. 
Plasmid DNA (5g) was linearised by treatment with Hind III, and transformed into 
Pichia pastoris strains SMD1168H and X-33 using standard Invitrogen kit protocols. 
Transformants were selected on antibiotic containing plates (100 μg/ml zeocin). 
 
Transgene copy number determination by quantitative PCR 
Selected yeast clones were grown in 10ml YPG medium (1% w/v yeast extract; 2% 
w/v peptone; 4% v/v glycerol; 100 g/ml zeocin) in baffled flasks with shaking at 
30°C for 72 h. Genomic DNA (gDNA) was extracted as described by Looke et al. 
2011[15]. and quantified by absorbance at 260nm using a Nanodrop 
spectrophotometer. Primers were designed to amplify partial sequences of 
MODHv1a/GNA, and the P. pastoris actin gene (PAS_chr3_1169, encoding Uniprot 
protein Q9P4D1) was used as an endogenous control for gene copy number, as 
follows: 
For MODHv1a/GNA amplification: Fwd 5’TGGTCTCTCCCGTAGCTGCTT; Rev 
5’ATCGAACAAACCGATTTGGG 
For Actin amplification: Fwd 5’ CGGTATGTGTAAGGCCGGATA; Rev 
5’ACGACCGATGGGAACACTGT 
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50ng of gDNA was used as a template for individual quantitative PCRs, with each 
reaction run in triplicate. Amplification was measured using fluorescence of SYBR 
Green on an Applied Biosystems StepOne instrument; Step One software was used to 
compare samples using the Ct method. 
 
Small-scale screening for fusion protein expression 
Selected clones were grown in small-scale (10 ml) cultures in YPG medium with 
shaking at 30° C for 48 h. After centrifugation (3000g, 10 min), 10l supernatant 
samples were analysed by SDS-PAGE followed by western blotting using anti-GNA 
antibodies, as described previously ([16] Fitches & Gatehouse, 1997), except that 
chemiluminescence detection was carried out using coumaric acid (0.2 mM) and 
luminol (1.25 mM) in 1 M Tris (pH 8.5) with the addition of 0.009% (v/v) hydrogen 
peroxide. Recombinant snowdrop lectin (GNA), purified to 100 % homogeneity was 
used as a standard to allow quantitative estimation of fusion protein expression.  
 
Bench-top fermentation experiments 
All runs were carried out in a 5 l capacity BioFlo 110 (New Brunswick) fermentation 
vessel with 2.5 l of basal salt minimal media (MM) supplemented with PTM1 salts 
([17] Cino, 1999). Fermenters were seeded with 180ml inoculum culture, grown in 
YPG medium (shaking at 30° C) for 48 h, and run at 30 °C. A sterile glycerol (50% 
v/v) feed of 1.25 l was introduced over a fermentation period of 72 h, maintaining 
dissolved oxygen at 30% and pH at 4.7- 4.9. 
Yield estimates following fermentation, were obtained by SDS-PAGE analysis  and 
western blotting. For western analysis samples were diluted in distilled water prior to 
loading. Gels (17.5 % acrylamide) were stained for total proteins with Coomassie 
Blue and blots were probed with anti-GNA antibodies, as described previously. 
Different loadings of purified GNA were used as a standard to give semi-quantitative 
estimates of fusion protein content. 
 
Purification of Hv1a/GNA and MODHv1a/GNA/His fusion proteins 
Purification of the non-modified recombinant Hv1a/GNA fusion protein was carried 
by hydrophobic interaction chromatography followed by a gel filtration clean-up step 
as described previously ([7] Fitches et al., 2012). Purification of 
MOD/Hv1a/GNA/His was carried out in a single step using nickel affinity 
chromatography on 5 ml HisTrap crude nickel columns (GE Healthcare). Briefly, 
one-third volume 4x binding buffer (BB; 0.4 M sodium chloride, 0.04 M sodium 
acetate; pH 7.4) was added to culture supernatants, and which were loaded then 
loaded onto columns equilibrated with BB at a flow rate of 2- 4 ml/min. Bound 
protein was eluted by the addition of imidazole (200mM) in BB. The eluted protein 
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peak was diluted 50:50 with distilled water, dialysed against distilled water and 
freeze-dried. For analysis of fusion protein content a known quantity was weighed 
and re-suspended in distilled water at a concentration of 10 mg/ml. Following 
centrifugation at 12000g for 2 min aliquots of supernatant were run on SDS-PAGE, 
using GNA standards run on the same gel to allow semi-quantitative estimation of 
fusion protein content after staining.  
 
Analysis of biological activity: injection bioassays 
Biological activity was assessed by injection of purified Hv1a/GNA and 
MODHv1a/GNA/His into newly moulted fifth instar cabbage moth (Mamestra 
brassicae) larvae. Proteins were re-suspended in distilled water at concentrations of 1 
– 4 μg/μl. Larvae were anesthetized with carbon dioxide for 10-20 sec prior to 
injecting 5 μl volumes using a Hamilton syringe with a 24 gauge needle. Controls 
were injected with distilled water. For each sample tested 20 larvae were injected per 
dose. Survival was monitored daily for 5 days. 
 
Results and Discussion 
The expression vector used as the basis for constructs was pGAPZB, a shuttle vector 
propagated in E. coli. The recombinant insecticidal fusion protein Hv1a/GNA, 
previously shown to be orally active against lepidopteran larvae, has potential for 
development as a biopesticide ([7] Fitches et. al., 2012). The basic construct for 
heterologous expression of the Hv1a/GNA fusion protein contained a coding 
sequence encodingencodes a hybrid protein composed of the yeast (S. cerevisiae) -
factor prepro-sequence, the -ACTX-Hv1A atracotoxin peptide (Hv1a), joined by a 
3-alanine linker region to the coding sequence for GNA (Galanthus nivalis agglutinin; 
snowdrop lectin) polypeptide (Fig. 1a). Expression of this construct results in 
secretion of the insecticidal Hv1a/GNA fusion protein, into culture supernatant of 
transformed P. pastoris. To date, the production of gram quantities of intact fusion 
protein required for field testing, has been hindered by problems associated with 
proteolytic cleavage during expression by P. pastoris, and by the relatively low levels 
of expression observed for protease deficient strains carrying single copy Hv1a/GNA 
expression cassettes. Here we report work carried out to improve levels of expression 
of intact Hv1a/GNA through modification of the Hv1a/GNA construct and 
subsequently the generation of a modified expression vector backbone that enabled 
the integration of multiple Hv1a/GNA expression cassettes. 
 
Construct modification and expression analyses 
The C-terminus of the Hv1a peptide (residues 33–36) includes the sequence -VKRC-, 
which is similar to the sequence -EKRE- that is present in the -factor signal 
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sequence of the pGAP expression vector. -EKRE- is cleaved between R and E by the 
P. pastoris Kex2 gene product. The 34th lysine residue in Hv1a was replaced with a 
glutamine residue by site directed mutagenesis and, following sequence verification, 
reassembled into an expression vector that was transformed into P. pastoris wild type 
X33 and protease deficient SMD1168H strains. Western blot analysis using anti-GNA 
antibodies enabled comparative analysis of the stability of the original Hv1a/GNA 
fusion protein with the modified MODHv1a/GNA/His in both nutrient rich (YPG) 
and minimal media (MM). As reported previously ([7] Fitches et al., 2012) the 
presence of two GNA immunoreactive bands on western blots corresponds to intact 
fusion protein and GNA from which the Hv1a toxin has been cleaved. Due to the 
presence of a histidine tag intact MODHv1a/GNA/His and cleaved GNA/His migrate 
at higher molecular masses than the non-modified Hv1a/GNA and cleaved GNA 
proteins. A composite of these experiments is presented Fig. 1b&c.  
Levels of intact Hv1a/GNA were found to be higher in both nutrient rich (YPG) and 
minimal media (MM) when the protein is expressed in the protease deficient strain as 
compared to the wild type strain (Fig. 1b). This has been reported previously for a 
fusion protein encoding a venom peptide SFl1, from the spider Segestria florentina, 
linked to GNA ([5] Fitches et al., 2004). In the case of SFI1/GNA, expression by X33 
cells was found to produce a 1:1 ratio of intact to cleaved protein, whereas 
predominantly intact SFI1/GNA was obtained using the protease deficient strain 
SMD1168H. Similarly for Hv1a/GNA, expression using SMD1168H cells resulted in 
75-100% intact fusion protein (0-25% cleaved GNA) as compared to 50-60% in X33 
(50-40 % cleaved GNA), depending on the composition of the culture media. 
Modification of the C-terminus of the toxin sequence resulted in a small increase in 
the levels of intact fusion protein in SMD1168H cells as compared to the original 
construct (Fig. 1b & c). This indicated that proteolysis during processing of the 
protein in the golgi apparatus by Kex2 membrane bound proteases may be slightly 
reduced. More significantly, toxin sequence modification resulted in a marked 
improvement (approx. 30 % Fig. 1b & c) in the levels of intact fusion protein being 
expressed in the wild type X33 strain as compared to Hv1a/GNA. This is indicative of 
reduced susceptibility to proteolytic cleavage by extracellular yeast proteases, such as 
carboxypeptidase Y and proteinase B, that are activated by vacuolar Peptidase A. 
Reduced proteolysis of the modified fusion protein was most evident for cells grown 
in bench-top fermentation in minimal media (MM) as compared to small-scale shake 
flask cultures in nutrient rich media. Previous studies have shown that intracellular 
vacuolar proteases are released from yeast cells during high-density cell growth and 
can play a significant factor in protein degradation ([18,19] Sinha et al., 2004; Li et 
al., 2007). Thus it is likely that the modified fusion protein has improved resistance to 
both extracellular and intracellular yeast proteases as compared to Hv1a/GNA.  
The release of intracellular proteases during high cell density fermentation may also 
account for the increased proteolysis of both Hv1a/GNA and MODHv1a/GNA 
observed in fermented cultures grown in minimal basal salt media as compared to 
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small-scale shake flask cultures grown in nutrient rich YPG media (Fig. 1b&c). It is 
also possible that the presence of additional proteins in YPG media may increase act 
as substrates for released proteases, decreasing the availability of the fusion proteins 
as substrates,availability and may thus have contributinged to a reduction in 
susceptibility of the recombinant fusion proteins to proteolysis.  
 
Analysis of biological activity: injection bioassays 
Purified Hv1a/GNA and MODHv1a/GNA/His were injected into lepidopteran larvae 
to investigate if modification of the C-terminus of the toxin peptide had any impact 
upon the insecticidal activity of the fusion protein. As shown in Table 1 levels of 
mortality observed for M. brassicae larvae injected with different doses of the original 
or modified fusion protein were highly similar verifying that mutagenesis of the Hv1a 
peptide had not disrupted or altered biological activity. Hv1a is a member of the -
ACTX-1 family of 36-37 insecticidal residue peptides isolated from the Australian 
funnel web spider that block insect but not vertebrate, voltage-gated calcium channels 
([20] Fletcher et al., 1997). Previous alanine scanning mutagenesis studies by Tedford 
et al., [21] 2004 have identified 3 key functional residues (Pro10, Asn27, and Arg35) 
that determine specific binding to insect calcium channels. Here replacement of the 
34th lysine residue in Hv1a with a glutamine residue by site directed mutagenesis was 
selected as glutamine is known to be present at this position of other members of the 
-ACTX-1 family ([22] Tedford et al 2004) and was thus unlikely to disrupt 
biological function of the recombinant toxin.  
 
Assembly of expression vector constructs containing multiple gene copies 
The expression vector used as the basis for constructs was pGAPZB, a expression 
shuttle vector propagated in E. coli which integrates into the P. pastoris genome by 
homologous recombination at the chr2-1_0437 locus, the gene encoding 
glyceraldehyde-3-phosphate dehydrogenase (GAP). The plasmid contains the entire 
promoter region of the GAP gene, which both drives expression of the incorporated 
coding sequence in P. pastoris, and directs recombination at a site in the 5' UTR 
determined by the restriction enzyme used to linearise the plasmid prior to yeast 
transformation. As a result of the recombination, the entire plasmid is incorporated 
into the P. pastoris genome, and the 5' UTRs of both the endogenous GAP gene and 
the introduced gene construct are reconstructed. 
To ensure multiple copies of recombinant gene carried by the vector are incorporated 
into the genome of P. pastoris, the approach followed was to produce vectors carrying 
multiple copies of the expression construct, using a strategy based on that described 
by Zhu et al., [13]. This approach is much more reliable than the earlier method of 
screening large numbers of transformants for "jackpot" high copy strains resulting 
from multiple integrations of a transforming plasmid ([23] Higgins and Cregg, 1998).  
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The strategy to obtain multi-copy expression vectors is summarised in Fig. 2. The 
vector backbone for the multi-copy plasmid was modified by insertion of a Hind III 
site near the Bln I site in the GAP gene 5' UTR; this modification changed a singletwo 
adjacent bases, and was designed not to affect promoter function. The resulting 
expression vector (pGAPZBH-MODHv1a/GNA(FP)) was transformed into P. 
pastoris and checked for expression; no difference to the original pGAPZB 
expression construct was observed. This construct gave the 1-copy baseline for 
subsequent manipulation. A restriction fragment containing the GAP promoter, the 
recombinant protein coding sequence, and the AOX gene 3' UTR was isolated by 
restriction of the original expression construct with Bam HI and Bgl II, and was 
ligated into the original construct restricted with Bam HI; selection of the correct 
orientation of the inserted fragment gave a construct (pGAPZ-2FP) from which a 
fragment containing 2 copies of the GAP promoter - coding sequence - AOX 3' UTR 
in the same orientation ("2 copy cassette") could be isolated by restriction with Bam 
H I and Bgl II, since the site where the two fragments join was not restrictable by 
either enzyme after the ligation. The multi-copy expression vectors were then built up 
by combining the 2-copy cassette with the modified expression vector pGAPZBH-
FP. For example, to produce the 3-copy expression vector, pGAPZBH-3FP, the 2 
copy cassette was ligated with pGAPZBH-FP which had been linearised by 
restriction with BamH I. Restriction analysis of the resulting clones was used to select 
a recombinant where the three copies of the cassette were in the same orientation; the 
resulting plasmid has a single BamH I site, which can be used to insert further 
cassettes. 
In practice, it was more efficient to use both 2-copy and 4-copy cassettes to produce 
multi-copy expression vectors; the 4-copy cassette was produced by ligation of a 2-
copy cassette into the pGAPZ-2FP plasmid in the correct orientation to allow a 4-
copy cassette to be excised by restriction with BamH I and Bgl II (Fig. 2). Addition of 
the 4-copy cassette to pGAPZH-FP gave pGAPZH-5FP; addition of the 2-copy 
and 4-copy cassettes to pGAPZH-5FP gave pGAPZH-7FP and pGAPZH-9FP; 
addition of the 4-copy cassette to pGAPZH-7FP gave pGAPZH-11FP. The larger 
plasmids became successively more difficult to transform into E. coli for cloning and 
propagation, and production of multi-copy expression vectors with more than 11 
copies of the expression construct was not found possible. 
 
The multi-copy expression constructs pGAPZH-3FP, pGAPZH-5FP, pGAPZH-
7FP, pGAPZH-9FP and pGAPZH-11FP were verified by restriction analysis; 
DNA sequencing was not feasible as the multiple cassettes all contained sequences 
corresponding to the pGAP sequencing primers. Linearisation of the plasmids at the 
single Hind III site in the pGAPZB backbone showed that plasmid size increased in 
line with predicted copy number (results not shown). 
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Yeast transformation and gene copy analysis of transformants 
Transformation of P. pastoris with the multi-copy expression vectors was carried out 
using normal procedures; selection on high levels of zeocin was not necessary. In 
contrast to transformation of E. coli with large plasmids, no significant fall-off in 
numbers of transformants obtained from the larger multicopy expression vectors was 
observed. Expression constructs were transformed into both the "wild-type" P. 
pastoris strain X-33, and the protease deficient strain SMD1168H. 
P. pastoris clones that were selected on the basis of zeocin resistance were screened 
for recombinant protein expression by western blot analysis of culture supernatant 
from small-scale shake flask cultures. These assays showed that >90% of the selected 
transformants produced detectable levels of the desired recombinant protein, 
MODHv1a/GNA/His, irrespective of the copy number of the multi-copy expression 
vector used for transformation. Clones were selected for further study on the basis of 
positive fusion protein expression in the small-scale screen. 
A selection of clones produced using single copy and multi-copy expression vectors 
were analysed by quantitative PCR to estimate the actual copy number of the fusion 
protein gene(s) incorporated into the yeast genome, by comparison to an endogenous 
single copy gene sequence. Analysis of 8 different clones for single copy, 3-copy, 5-
copy, 7 copy, 9-copy and 11 copy transformants in P. pastoris SMD1168H, and 11-
copy transformants in P. pastoris X-33 is presented in Fig. 3. These results are typical 
of other analyses carried out on multi-copy transformants. 7/8 of the single copy 
transformant clones contain a single integrated gene for MODHv1a/GNA, with the 
remaining clone containing 2 copies. Of the nominal 3-copy clones, 4/8 do contain 3 
copies, with the remaining clones containing 1-2 copies; the "5-copy" clones have 2/8 
with 5 copies, 6/8 with 1-3 copies; the "7-copy" clones have 2/8 with 7 copies, 6/8 
with 1-6 copies; the "9-copy" clones have 2/8 with 9 copies, and 6/8 with 2-7 copies; 
and the "11-copy" clones have 4/16 with 11 copies, and 12/16 with 4-8 copies. These 
results show that clones produced using the multi-copy expression vectors are liable 
to loose copies of the expression cassette during the transformation process but that 
intact multi-copy integration also occurs at a viable frequency. The results in the two 
yeast strains were similar.  
 
Recombinant protein expression from P. pastoris clones 
The small-scale screen of clones for expression of MODHv1a/GNA/His showed an 
approximate correspondence between levels of expression and the number of gene 
copies present in the yeast clones, but expression from clone to clone was variable 
(results not presented). This variability is likely to be due to differences in parameters 
such as oxygen level and pH in small-scale cultures. The influence of copy number on 
protein expression is not predictable [24] and to allow a more accurate comparison of 
production of recombinant protein, a series of clones were selected for pilot-scale 
bench-top fermentation, under controlled conditions. The clones were selected on the 
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basis of qPCR results, which showed 1, 2, 5, 9 and 11 fusion protein gene cassettes to 
be present in strain SMD1168H clones, and 9 and 11 copies in strain X-33 clones. 
Results are summarised in Table 2. 
 
Growth parameters for the different multi-copy expression clones in the fermenter 
suggested that the multi-copy clones in strain X-33 grew better than any of the clones 
in the protease deficient strain, as would be expected. The clones in strain X-33 also 
had higher pellet weights at the end of the fermentation (Table 2). When culture 
supernatants from the fermenter runs were analysed for protein content, it was clear 
that the multi-copy expression clones were able to produce enhanced levels of 
recombinant MODHv1a/GNA. The basal level of expression from a single copy clone 
in strain SMD1168H for the original Hv1a/GNA construct was approx. 50 mg/l 
whereas for the modified construct (MODHv1a/GNA) this the fusion protein level 
was approx. 100 mg FP / l culture supernatant. There were no consistent or significant 
differences in growth between 2, 5 and 9-copy clones in strain SMD1168H, 
suggesting that any increased production of recombinant protein in the multi-copy 
clones was not limiting growth. However, although similar yields of fusion protein  
(600 mg/l) were observed for the 5 and 9-copy SMD1168H clones, and a notable 
reduction in expression level (200 mg/l) was recorded for the 11 copy SMD1168H 
clone. These results suggested that the optimal copy number for fusion protein 
expression in the Protease deficient strain was 5. By contrast, the optimal copy 
number for fusion protein expression levels using wild type cells was found to be 
higher than that observed for protease deficient cells. Maximum expression (1 gram/l) 
was recorded following fermentation of a 9-copy clone. As observed for the protease 
deficient clones expression levels were then seen to decrease with increasing copy 
number.  
These results are comparable with those reported by Zhu et al. (2009) [13], where 
production of a recombinant protein using a methanol-induced vector in P. pastoris 
increased approximately 10-fold when increasing gene copy number from 1 to 12, but 
decreased when vectors with higher copy numbers were introduced. In addition Zhu 
et al., [13] found a reduction in cell growth rate with strains carrying more than the 
optimal 12 copies of the transgene. In this study a reduction in cell growth rate was 
noted for SMD1168H cells carrying more than 5 copies of the transgene but this was 
not observed for X33 cells. John Is it possible that the FP5 cassette drops out of the 
yeast and so cells not expressing fusion protein are growing in the higher copy 
fermntation runs?? 
  
As shown in Fig. 4 the purified recombinant fusion protein product from multi-copy 
strains of P. pastoris gave a similar band pattern on SDS-PAGE to the product from a 
single copy strain. Furthermore SDS-PAGE analysis of samples derived from 
fermentation of the highest expressing clone demonstrated that the fusion protein is 
Comment [JG2]: There is clearly 
recombination to decrease copy 
number during transformation, but 
once the strains are established, 
they should be stable. It is possible 
that no0n-expressing mutants are 
being selected for in fermentation 
runs, but yeast should be reasonably 
stable. 
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the most abundant protein representing more than 50% of the total protein in the 
culture supernatant. 
 
Conclusion 
In the present study we provide evidence to show that a single amino acid change in a 
recombinant hybrid protein sequence can have a significant impact on resistance to 
yeast proteases without loss of biological function. Furthermore, the data presented 
show that producing strains of P. pastoris containing multiple copies of a transgene 
expression construct results in increased expression levels of recombinant proteins 
when a constitutive, rather than an induced promoter is used, and identifies likely 
limits for recombinant protein production in this system. The increase in expression 
level of Hv1a/GNA has made production of this fusion protein on an industrial scale 
at a viable cost possible, so that it can be taken forward for evaluation as a novel 
biopesticide. 
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Figure legends 
Fig. 1(A) Diagrammatic representation of Hv1a/GNA and modified (MOD) 
Hv1a/GNA constructs showing linker region sequence and predicted molecular 
masses of Hv1a and GNA components. The location and identity of the modified 
amino acid in the Hv1a peptide is depicted in white text. (B) Composite of western 
analysis (anti-GNA antibodies) of culture supernatants derived from small-scale YPG 
and bench-top fermented (MM) samples of Hv1a/GNA and MODHv1a/GNA/His 
expressing SMD1168H or X33 clones. Arrow depicts GNA standard (25 ng). (C) 
Table showing estimated percentage of intact fusion protein present in Hv1a/GNA 
and MODHv1a/GNA/His supernatants derived from western analysis in 1B.  
 
Fig. 2 Diagrammatic representation of the cloning strategy adopted to enable insertion 
of multiple copies of the fusion protein cassette into the Pichia yeast genome. (A) 
Location of Hv1a/GNA cassette and position of inserted Hind III site in the promoter 
region of pGAPZB expression vector. (B) Procedure for vector restriction and 
ligation of fusion protein cassettes to create multi-copy expression cassettes in E. coli 
prior to transformation into yeast.  
 
Fig. 3 Quantitative PCR analyses of yeast clones derived from transformation of 
single and multi-copy fusion protein cassettes. Actin was used as an endogenous 
control. To be completed 
 
Fig. 4 SDS-PAGE (17.5 % acrylamide gels) analyses of (A) Purified Hv1a/GNA and 
MODHv1a/GNA/His derived from fermentation of single copy SMD1168H clones 
and (B) Culture supernatant and purified MODHv1a/GNA/His samples derived from 
fermentation of 9-copy X33 clone. M denotes molecular scale protein marker mix. 
Loading in g of intact fusion protein or GNA standards (A & B) or l of culture 
supernatant (B) is denoted. 
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Fig. 2.We need to get rid of FP5 and replace with FP 
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 Table 1. Yields of recombinant protein product FP5 from 5 l scale fermentations of 
different clones of P. pastoris estimated by SDS-PAGE and western analysis (anti-
GNA antibodies). 
 
Clone 
Number 
Gene 
Copy 
Number 
Strain 
Final wet cell 
density (mg/ml) 
Yield estimate 
(mg/l) 
4/1 1 SMD1168H 325 100 
3/1 2 SMD1168H 316 200 
3/11 2 SMD1168H 375 200 
5/5 5 SMD1168H 386 600 
3/7 5 SMD1168H 455 600 
2/5 9 SMD1168H 350 600 
7/11 11 SMD1168H 365 200 
     
1/11 9 X-33 420 1000 
5/5 11 X-33 416 600 
 
 
 
 
 Table 2. Mortality recorded for fifth stadium M. brassicae larvae 72 h after injection 
of different concentrations of recombinant Hv1a/GNA and MODHv1a/GNA/His re-
suspended in dstilled water. Controls were injected with distilled water. 
 
 
Treatment Dose fusion 
protein (g) 
Mortality Sample No. 
Control - 0 40 
Hv1a/GNA 20 90 20 
 10 45 20 
 5 0 20 
MODHv1a/GNA 20 100 20 
 10 35 20 
 5 0 20 
 
